FDA.reportPublic FDA data

enfortumab vedotin-ejfv 30 MG Injection

RxCUI
2268317
RxNorm name
enfortumab vedotin-ejfv 30 MG Injection
Display name
enfortumab vedotin-ejfv 30 MG Injection
Full name
enfortumab vedotin-ejfv 30 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761137Padcevenfortumab vedotin-ejfv351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PADCEV EJFVENFORTUMAB VEDOTINSEAGEN INC.b5631d3e-4604-4363-8f20-11dfc5a4a8ed2026-07-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2268317

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
b5631d3e-4604-4363-8f20-11dfc5a4a8edenfortumab vedotin-ejfv 30 MG InjectionPSN16These highlights do not include all the information needed to use PADCEV safely and effectively. See full prescribing information for PADCEV. PADCEV ® (enfortumab vedotin-ejfv) for injection, for intravenous use Initial U.S. Approval: 201920251121
b5631d3e-4604-4363-8f20-11dfc5a4a8edenfortumab vedotin-ejfv 30 MG InjectionSCD16These highlights do not include all the information needed to use PADCEV safely and effectively. See full prescribing information for PADCEV. PADCEV ® (enfortumab vedotin-ejfv) for injection, for intravenous use Initial U.S. Approval: 201920251121